Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
Tuberous sclerosis complex (TSC) is an autosomal dominant neurogenetic disorder affecting the brain and other vital organs. Neurological symptoms include epilepsy, intellectual disability, and autism. TSC is caused by a loss-of-function mutation in the TSC1 or TSC2 gene. These gene products form a p...
Main Authors: | Rebecca L. Cox, Froylan Calderon de Anda, Tomer Mangoubi, Akira Yoshii |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2018.00409/full |
Similar Items
-
Sodium hydroxide enhances the efficacy of rapamycin to suppress proliferation of Tsc2-null mouse embryonic fibroblasts
by: LI Kai, WANG Ya-nan
Published: (2021-07-01) -
A brain proteomic investigation of rapamycin effects in the Tsc1 +/− mouse model
by: Hendrik Wesseling, et al.
Published: (2017-08-01) -
Use of topical rapamycin in facial angiofibromas in Indian skin type
by: Vishalakshi Viswanath, et al.
Published: (2016-01-01) -
Progress in the Treatment of Topical Rapamycin Preparations
by: WANG Senfen, et al.
Published: (2023-04-01) -
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013-01-01)